Award-winning MammoScreen® 2D&3D provides AI-guided decision-making support for breast cancer screening,
enabling you to decisively confirm what you suspect, detect what you potentially missed
and concentrate on questionable studies that need more attention.
Product
For 2D&3D, MammoScreen® uses the proprietary MammoScreen Score™ to provide at-a-glance level-of-suspicion scoring of studies; confirming findings that are certain, and questionable cases that require further scrutiny.
Confidence in
your diagnosis
Reading mammograms combines your skill and experience as a radiologist with multiple data inputs—lesion type, breast density and patient history. Each image demands deep, informed concentration. For 2D&3D, MammoScreen®’s AI software works alongside your viewer to give you additional confidence.
Efficiency
defined.
With increasing workloads radiologists are expected to perform more reads in the same amount of time. MammoScreen® 2D&3D allows you to read benign cases in less time.
News & Events
Therapixel Connects to Nuance Precision Imaging Network to Empower Collaborative Care Teams and Improve Patient Outcomes with Workflow-Integrated AI
New collaborative effort between Therapixel and Nuance
Arterys and Therapixel Team Up for AI-Powered Breast Cancer Solution
New collaborative effort between Therapixel and Arterys
Case of the week (week 16, 2023)
MammoScreen in clinical practice